Retrospective Study of the Prevalence of Hyperkalemia in Women Taking Spironolactone for Acne, Hair Loss, and Hirsutism

    September 2022 in “ Journal of The American Academy of Dermatology ”
    Rachel Hill, Yu Wang, Shari R. Lipner
    Studysummary This study measured hyperkalemia rates in women using spironolactone for acne, hair loss, and hirsutism to evaluate the necessity of laboratory monitoring, examining variations among different age, racial, and ethnic groups.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaad.org →
    Discuss this study in the Community →

    Related research 7

    1. Retrospective Study of the Prevalence of Hyperkalemia in Women Taking Spironolactone for Acne, Hair Loss, and Hirsutism Journal of The American Academy of Dermatology · 2022
    2. Retrospective Study of the Prevalence of Hyperkalemia in Women Taking Spironolactone for Acne, Hair Loss, and Hirsutism Journal of The American Academy of Dermatology · 2022
    3. Spironolactone in Dermatology: Uses in Acne, Hidradenitis Suppurativa, Female Pattern Hair Loss, and Hirsutism Actas Dermo-Sifiliográficas · 2020
    4. Androgens in Women: Hormone-Modulating Therapies for Androgen-Mediated Cutaneous Disorders Journal of The American Academy of Dermatology · 2018
    5. Spironolactone in Dermatological Treatments Der Hautarzt · 2013
    6. Comparison of Flutamide and Spironolactone in the Treatment of Hirsutism: A Randomized Controlled Trial Fertility and Sterility · 1994
    7. Oral Spironolactone Therapy for Female Patients with Acne, Hirsutism, or Androgenic Alopecia British Journal of Dermatology · 1985